Gender, sex steroids, and cerebral ischemic pathobiology

3Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Biological sex is an important genetic determinant of outcome from cerebral ischemia and clinical stroke. Emerging data suggest that sex, as well as reproductive steroids, shapes ischemic cell death in brain. Female sex steroids, the estrogens and progesterone, provide robust neuroprotection in a variety of experimental settings and strongly contribute to sex-specific responses to ischemia. The purpose of this chapter is: (1) to review the importance of biological sex to ischemic outcome and mechanisms of brain injury, (2) to evaluate the role of female sex steroids as endogenous or exogenous ischemic neuroprotectants, and (3) to review most likely mechanisms by which female sex steroids act to interrupt ischemic cell death pathways. © 2007 Springer-Verlag US.

Cite

CITATION STYLE

APA

Koerner, I. P., Murphy, S. J., & Hurn, P. D. (2007). Gender, sex steroids, and cerebral ischemic pathobiology. In Handbook of Neurochemistry and Molecular Neurobiology: Acute Ischemic Injury and Repair in the Nervous System (pp. 185–207). Springer US. https://doi.org/10.1007/978-0-387-30383-3_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free